Evidence map›Paper›PMID 25820115›Full record

ArticleScientific reports2015

Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics.

Sinyoung Jeong, Yong-il Kim, Homan Kang, Gunsung Kim, Myeong Geun Cha, Hyejin Chang, Kyung Oh Jung, Young-Hwa Kim, Bong-Hyun Jun, Do Won Hwang and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Plasmonic Nanoparticles: Advanced Researches (II).Advances in experimental medicine and biology · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Raman Spectroscopy and Imaging for Cancer Diagnosis.Journal of healthcare engineering · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sinyoung JeongDepartment of Chemistry Education, Seoul National University, Seoul 151-744, Republic of Korea.
Yong-il Kim1] Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea [2] Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 151-747, Republic of Korea.
Homan KangInterdisciplinary Program in Nano-Science and Technology, Seoul National University, Seoul 151-744, Republic of Korea.
Gunsung KimDepartment of Chemistry Education, Seoul National University, Seoul 151-744, Republic of Korea.
Myeong Geun ChaDepartment of Chemistry Education, Seoul National University, Seoul 151-744, Republic of Korea.
Hyejin ChangDepartment of Chemistry Education, Seoul National University, Seoul 151-744, Republic of Korea.
Kyung Oh JungLaboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.
Young-Hwa KimDivision of High-Risk Pathogen Research, Center for Infectious Diseases and Prevention, Korea National Institute of Health, Seoul 110-799, Republic of Korea.
Bong-Hyun JunDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 143-701, Republic of Korea.
Do Won Hwang1] Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea [2] Cancer Imaging Center, Seoul National University Cancer Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.
Yun-Sang LeeDepartment of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea.
Hyewon Youn1] Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea [2] Cancer Imaging Center, Seoul National University Cancer Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.
Yoon-Sik Lee1] Interdisciplinary Program in Nano-Science and Technology, Seoul National University, Seoul 151-744, Republic of Korea [2] School of Chemical and Biological Engineering, Seoul National University, Seoul 151-747, Republic of Korea.
Keon Wook KangDepartment of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea.
Dong Soo Lee1] Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea [2] Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 151-747, Republic of Korea.
Dae Hong Jeong1] Department of Chemistry Education, Seoul National University, Seoul 151-744, Republic of Korea [2] Interdisciplinary Program in Nano-Science and Technology, Seoul National University, Seoul 151-744, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical endoscopic imaging, which was recently equipped with bioluminescence, fluorescence, and Raman scattering, allows minimally invasive real-time detection of pathologies on the surface of hollow organs. To characterize pathologic lesions in a multiplexed way, we developed a dual modal fluorescence-Raman endomicroscopic system (FRES), which used fluorescence and surface-enhanced Raman scattering nanoprobes (F-SERS dots). Real-time, in vivo, and multiple target detection of a specific cancer was successful, based on the fast imaging capability of fluorescence signals and the multiplex capability of simultaneously detected SERS signals using an optical fiber bundle for intraoperative endoscopic system. Human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) on the breast cancer xenografts in a mouse orthotopic model were successfully detected in a multiplexed way, illustrating the potential of FRES as a molecular diagnostic instrument that enables real-time tumor characterization of receptors during routine endoscopic procedures.

Indexed as

Pathology, MolecularAnimalsBreast NeoplasmsCell Line, TumorEndoscopyErb-b2 Receptor Tyrosine KinasesErbB ReceptorsFemaleHumansMiceSpectrometry, FluorescenceSpectrum Analysis, RamanXenograft Model Antitumor AssaysEGFR protein, humanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesErbB Receptors

Identifiers

PMID25820115
PMCPMC4377550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.